Obayashi

Obayashi Corporation is a prominent Japanese construction and engineering conglomerate that has strategically expanded into the biotechnology and life sciences sectors. Through its 'Green Biotech' initiative, the company leverages its engineering expertise to develop advanced bio-manufacturing facilities, including Cell Processing Centers (CPCs) for regenerative medicine. Obayashi is particularly active in microalgae cultivation for the production of high-value compounds like astaxanthin and is developing a bio-foundry platform to support the bio-economy. The company also focuses on sustainable solutions, including CO2 fixation and the development of bio-based materials in collaboration with synthetic biology startups. By integrating construction expertise with biological sciences, Obayashi aims to play a central role in the emerging global bio-economy.